Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Athena Diagnostics | RCV000084538 | SCV000842705 | likely pathogenic | not provided | 2018-01-23 | criteria provided, single submitter | clinical testing | |
| Gene |
RCV000084538 | SCV005421320 | uncertain significance | not provided | 2024-06-04 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this variant does not alter splicing; Nucleotide is not conserved across species and the substitution has no predicted effect on splicing; This variant is associated with the following publications: (PMID: 19914360, 30793898, 12615641, 37563653, 31031559) |
| Labcorp Genetics |
RCV005089560 | SCV005767076 | uncertain significance | Frontotemporal dementia | 2024-05-16 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 9 of the MAPT gene. It does not directly change the encoded amino acid sequence of the MAPT protein. This variant is present in population databases (rs63750162, gnomAD 0.01%). This variant has been observed in individual(s) with frontotemporal dementia (PMID: 12615641, 19884572). ClinVar contains an entry for this variant (Variation ID: 98223). Studies have shown that this variant is associated with inconclusive levels of altered splicing (PMID: 12615641, 19914360, 30793898). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| VIB Department of Molecular Genetics, |
RCV000084538 | SCV000116674 | not provided | not provided | no assertion provided | not provided |